Apyx Medical (NASDAQ:APYX) Now Covered by BTIG Research

Stock analysts at BTIG Research initiated coverage on shares of Apyx Medical (NASDAQ:APYX) in a note issued to investors on Thursday, Briefing.com reports. The brokerage set a “neutral” rating on the stock.

Separately, JMP Securities restated a “market perform” rating on shares of Apyx Medical in a research note on Monday, September 16th.

Apyx Medical Price Performance

Shares of Apyx Medical stock opened at $1.23 on Thursday. The company has a debt-to-equity ratio of 2.26, a current ratio of 5.33 and a quick ratio of 4.45. Apyx Medical has a fifty-two week low of $0.97 and a fifty-two week high of $3.26. The firm has a fifty day moving average price of $1.22 and a two-hundred day moving average price of $1.36. The company has a market cap of $42.61 million, a PE ratio of -1.86 and a beta of 1.20.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. The company had revenue of $12.15 million during the quarter, compared to the consensus estimate of $12.67 million. During the same period last year, the company earned ($0.11) earnings per share. Analysts expect that Apyx Medical will post -0.7 EPS for the current year.

Hedge Funds Weigh In On Apyx Medical

Hedge funds have recently made changes to their positions in the business. Kingsview Wealth Management LLC raised its stake in shares of Apyx Medical by 156.7% in the 1st quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock valued at $42,000 after buying an additional 18,943 shares in the last quarter. RPg Family Wealth Advisory LLC acquired a new stake in shares of Apyx Medical during the 2nd quarter worth about $101,000. Perkins Capital Management Inc. increased its position in shares of Apyx Medical by 7.0% during the 1st quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock worth $311,000 after purchasing an additional 15,000 shares in the last quarter. Rathbones Group PLC increased its position in shares of Apyx Medical by 148.0% during the 2nd quarter. Rathbones Group PLC now owns 251,334 shares of the company’s stock worth $337,000 after purchasing an additional 150,000 shares in the last quarter. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Apyx Medical during the 1st quarter worth about $676,000. Institutional investors and hedge funds own 55.33% of the company’s stock.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.